| 1 |
35086099 | Polymorphism in Thymidylate Synthase Gene Predicts Survival and Toxicity in North Indian Lung Cancer Patients Undergoing Platinum-Based Doublet Chemotherapy. | 2022 Jan 27 |
4 |
| 2 |
34141464 | Expression and gene regulation network of TYMS and BCL2L1 in colorectal cancer based on data mining. | 2021 |
1 |
| 3 |
31561530 | Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth. | 2019 Sep 26 |
1 |
| 4 |
29861877 | SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand. | 2018 May 18 |
1 |
| 5 |
29187479 | Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung Cancer. | 2017 Dec |
1 |
| 6 |
26740498 | Poor response to platinum-based chemotherapy is associated with KRAS mutation and concomitant low expression of BRAC1 and TYMS in NSCLC. | 2016 Feb |
1 |
| 7 |
25573098 | Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy. | 2015 May |
1 |
| 8 |
26638920 | Biomarkers and prognostic factors for malignant pleural mesothelioma. | 2015 |
1 |
| 9 |
24554028 | Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. | 2014 May |
3 |
| 10 |
25246386 | Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients. | 2014 Nov |
1 |
| 11 |
23645741 | Thymidylate synthase gene copy number as a predictive marker for response to pemetrexed treatment of lung adenocarcinoma. | 2013 May |
2 |
| 12 |
22866924 | Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS). | 2012 Aug 6 |
1 |
| 13 |
21970874 | Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin. | 2011 Nov 8 |
1 |
| 14 |
17465714 | Pharmacogenetics and stomach cancer: an update. | 2007 May |
1 |